BioSpace News Archive

Business

Laboratory for Advanced Medicine Names Jinjie Hu as Chief Regulatory Officer

Laboratory for Advanced Medicine announced that the Company has recently appointed Dr. Jinjie Hu as its Chief Regulatory Officer.

July 12, 2018
·
3 min read
Business

BioIQ is Humanizing Analytics and Helping Healthcare Organizations Close the Gap Between Data and Performance

BioIQ has announced the advancement of the BioIQ analytics platform.

July 12, 2018
·
2 min read
Business

Castlight Health to Announce Second Quarter 2018 Results

Castlight Health, Inc. will release its second quarter 2018 financial results on Monday, July 30, 2018

July 12, 2018
·
1 min read
Business

GeneNews’ Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer

GeneNews Limited announced the appointment of David Byram as the Chief Commercial Officer for its U.S. Lab, Innovative Diagnostic Laboratory, LLP

July 12, 2018
·
3 min read
Deals

Natera Announces Pricing of Follow-On Offering of 4,500,000 Shares of its Common Stock

Natera, Inc. announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $20.00 per share.

July 12, 2018
·
2 min read
Business

Incyte to Report Second Quarter 2018 Financial Results

Incyte Corporation announced that it has scheduled its second quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 31, 2018.

July 12, 2018
·
1 min read
Drug Development

Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye Disease

Oyster Point Pharma, Inc., today announced results from the PEARL study, a Phase 2b clinical trial evaluating the company’s novel therapy for the treatment of Dry Eye Disease (DED).

July 12, 2018
·
5 min read
Policy

Ceterix Orthopaedics Awarded New U.S. Patent for Circumferential Suturing Method in Meniscus Repair

New Patent Further Protects the Unique Circumferential Compression Stitch Method and Expands the Company’s Intellectual Property Portfolio for Orthopaedic Applications

July 12, 2018
·
3 min read
Business

X4 Pharmaceuticals Appoints Michael Wyzga as Chair of Board of Directors

Mr. Wyzga brings leadership experience, including in rare diseases and cancer

July 12, 2018
·
2 min read
Drug Development

Seattle Genetics Announces First Patient Dosed in Phase 2 innovaTV 207 Trial Evaluating Tisotumab Vedotin in Multiple Solid Tumors

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced dosing of the first patient in the phase 2 innovaTV 207 clinical trial.

July 12, 2018
·
5 min read